Henry Guerra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Henry Guerra has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Carlos A. Castaneda
Instituto Nacional de Enfermedades Neoplasicas 2 , Lima, Peru
2 shared publications - Henry Leonidas Gomez
Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
2 shared publications - Joselyn Sanchez
Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
2 shared publications - Luis A. Bernabe
Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
2 shared publications - María del Rosario Villa Robles
Instituto Nacional de Enfermedades Neoplásicas. Lima, Perú. Bióloga, Magíster en Bioquímica
2 shared publications - Miluska Castillo
Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
2 shared publications
Latest Publications
- 29 October 2020
- Published by thinkBiotech, LLC in Journal of Commercial Biotechnology
- Vol. 25 (3)
Could COVID-19 Cause ‘Biopharming’ to Bloom?
At an accelerated rate in response to the COVID-19 pandemic, academic and corporate scientists are using genetic engineering techniques to reprogram plants to produce significant concentrations of high-value pharmaceuticals. The concept is not new. Many common medicines, such as certain opiates, the laxative Metamucil, and the anti-cancer drug Taxol, are all purified from plants, and efficacy has been shown for some herbals in Traditional Chinese Medicine. There is great potential for cost-cutting in the process: The energy for product synthesis comes from the sun, and the primary raw materials are water and carbon dioxide. In addition, biopharming offers tremendous flexibility and economy when adjustments in production are necessary. The need for inexpensive, flexible production techniques for COVID-19 therapeutics and vaccines could be a potent stimulus to biopharming research and development.
- 29 October 2020
- Published by thinkBiotech, LLC in Journal of Commercial Biotechnology
- Vol. 25 (3)
Could COVID-19 Cause ‘Biopharming’ to Bloom?
At an accelerated rate in response to the COVID-19 pandemic, academic and corporate scientists are using genetic engineering techniques to reprogram plants to produce significant concentrations of high-value pharmaceuticals. The concept is not new. Many common medicines, such as certain opiates, the laxative Metamucil, and the anti-cancer drug Taxol, are all purified from plants, and efficacy has been shown for some herbals in Traditional Chinese Medicine. There is great potential for cost-cutting in the process: The energy for product synthesis comes from the sun, and the primary raw materials are water and carbon dioxide. In addition, biopharming offers tremendous flexibility and economy when adjustments in production are necessary. The need for inexpensive, flexible production techniques for COVID-19 therapeutics and vaccines could be a potent stimulus to biopharming research and development.
- 17 October 2019
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 13 (17) , 1481-1491
Level of Tumor-Infiltrating Lymphocytes and Density of Infiltrating Immune Cells in Different Malignancies
Aim: To correlate levels of tumor-infiltrating lymphocytes (TIL) evaluated using the International Immuno-Oncology Biomarker Working Group methodology, and both density of tumor-infiltrating immune...
- 17 October 2019
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 13 (17) , 1481-1491
Level of Tumor-Infiltrating Lymphocytes and Density of Infiltrating Immune Cells in Different Malignancies
Aim: To correlate levels of tumor-infiltrating lymphocytes (TIL) evaluated using the International Immuno-Oncology Biomarker Working Group methodology, and both density of tumor-infiltrating immune...
- Open Access
- 13 August 2019
- Published by Hospital de Especialidades Carlos Andrade Marin
Síndrome Neuroléptico Maligno: A propósito de un caso clínico
- 13 August 2019
- Published by Hospital de Especialidades Carlos Andrade Marin
Open AccessSíndrome Neuroléptico Maligno: A propósito de un caso clínico
- 22 July 2019
- Published by Hindawi Limited in The Breast Journal
- Vol. 25 (6) , 1316-1319
Role of undifferentiation markers and androgen receptor expression in triple‐negative breast cancer
Click on the article title to read more.
- 22 July 2019
- Published by Hindawi Limited in The Breast Journal
- Vol. 25 (6) , 1316-1319
Role of undifferentiation markers and androgen receptor expression in triple‐negative breast cancer
Click on the article title to read more.
- Open Access
- 8 June 2019
- Published by Universidad de San Martin de Porres in Horizonte Médico (Lima)
- Vol. 19 (2) , 93-96
Coriocarcinoma gástrico primario: reporte de caso
- 8 June 2019
- Published by Universidad de San Martin de Porres in Horizonte Médico (Lima)
- Vol. 19 (2) , 93-96
Open AccessCoriocarcinoma gástrico primario: reporte de caso